Delivery Order SPE2DB22D2206-SPE2DB24FFG72
- Not listed
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,358.67 and is a firm-fixed-price delivery order, with a period of performance ending on February 6, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S medical supplies to the Defense Logistics Agency (DLA), a key agency within the U.S. Department of Defense. The $38,782.61 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 4, 2022 and was not set aside for any specific business type, indicating open competition....
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, on January 8, 2024. The contract has a ceiling value of $3,041.01 and a completion date of January 9, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award is for the delivery of 4560895403 MULTAQ 400 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $9,587.31 and an ultimate completion date of May 11, 2023. It is a firm fixed-price delivery order contract and was not set aside for any specific business category. Amerisourcebergen holds a...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $7,377.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,287.15 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set-aside and was awarded on April 16, 2025, with a completion date of April 17, 2025....
- This federal contract award is a delivery order for MULTAQ 400 MG TABLET 60S, valued at $6,445.14, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a firm fixed-price arrangement with a completion date of November 4, 2022. Amerisourcebergen Drug Corp is a for-profit pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to various federal agencies,...
- This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,455.95 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 30, 2022, with a completion date of March 31, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are registered in the System for Award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTAQ 400 MG TABLET 60S. The $5,798.82 firm-fixed-price delivery order has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the delivery of a pharmaceutical product, MULTAQ 400 MG TABLET 60S, to the Medical Supply Chain, which is an alternate name for the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,602.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFG72Delivery Order
This federal contract award is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $37,588.28. The contract has an ultimate completion date of January 26, 2024, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.6k | 1/25/24 |